Spyre Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spyre Therapeutics, Inc. has filed 781 SEC EDGAR filings since 24 Mar 2015

SEC filing history

Showing 101-103 of 103 matching filings.

Per page
25
Current page
5
SC 13G File 005-89456

13G INITIAL MONTHLY FILING (AGLE)

Filing date
09 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89456

SCHEDULE 13G

Filing date
18 Apr 2016
Reporting date
Not listed
Next action
Verify source filing
SC 13G File 005-89456

NOVARTIS BIOVENTURES LTD. SC 13G 4-6-2016 (AEGLEA BIOTHERAPEUTICS, INC)

Filing date
14 Apr 2016
Reporting date
Not listed
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .